ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,599.86
1.13%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Agile Therapeutics Inc (AGRX)

  7. Agile Therapeutics Inc (AGRX) 뉴스

AGRX

Agile Therapeutics (AGRX)

Agile Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AGRX
일자시간출처헤드라인심볼기업
2024/03/2821:05GlobeNewswire Inc.Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:AGRXAgile Therapeutics Inc
2024/03/2605:30GlobeNewswire Inc.Agile Therapeutics Announces Delisting from NasdaqNASDAQ:AGRXAgile Therapeutics Inc
2024/03/2119:35GlobeNewswire Inc.Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024NASDAQ:AGRXAgile Therapeutics Inc
2024/03/2021:15GlobeNewswire Inc.Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024NASDAQ:AGRXAgile Therapeutics Inc
2024/03/1320:31GlobeNewswire Inc.Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan ExecutionNASDAQ:AGRXAgile Therapeutics Inc
2024/02/2406:57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AGRXAgile Therapeutics Inc
2024/02/2406:55Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AGRXAgile Therapeutics Inc
2024/02/2223:01GlobeNewswire Inc.Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross ProceedsNASDAQ:AGRXAgile Therapeutics Inc
2024/02/1606:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
2024/02/1606:30GlobeNewswire Inc.Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance UpdateNASDAQ:AGRXAgile Therapeutics Inc
2024/02/1410:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
2024/02/0806:51Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
2024/02/0700:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
2024/02/0523:21Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
2024/02/0306:27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
2024/01/2323:29GlobeNewswire Inc.The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without CostNASDAQ:AGRXAgile Therapeutics Inc
2023/12/2022:00Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
2023/12/1222:01GlobeNewswire Inc.Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage RequirementNASDAQ:AGRXAgile Therapeutics Inc
2023/12/1207:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:AGRXAgile Therapeutics Inc
2023/12/0622:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
2023/12/0422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
2023/11/1006:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AGRXAgile Therapeutics Inc
2023/11/0922:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
2023/11/0922:05GlobeNewswire Inc.Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:AGRXAgile Therapeutics Inc
2023/10/2621:05GlobeNewswire Inc.Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023NASDAQ:AGRXAgile Therapeutics Inc
2023/10/0505:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGRXAgile Therapeutics Inc
2023/10/0505:30GlobeNewswire Inc.Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AGRXAgile Therapeutics Inc
2023/10/0305:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
2023/09/2905:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
2023/09/0521:05GlobeNewswire Inc.Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AGRXAgile Therapeutics Inc
 검색 관련기사 보기:NASDAQ:AGRX

최근 히스토리

PM
XAUUSD
Gold vs US Dollar
NASDAQ
AMZN
Amazon.com
SPI
SP500
S&P 500
NYSE
NKE
Nike
USOTC
BNPQY
BNP Paribas (QX)
NYSE
BAC
Bank of America
NYSE
MRK
Merck
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
CVX
Chevron
NYSE
VZ
Verizon Communications
AMEX
XLF
Financial Select Sector
FX
USDJPY
US Dollar vs Yen
AMEX
XLV
Health Care Select Sector
NASDAQ
TSLA
Tesla
COIN
BTCUSD
Bitcoin
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유